A Phase 1/2 Trial of ADI-212 in mCRPC | MicrobiomeTrials← Back to trialsNCT07793435
A Phase 1/2 Trial of ADI-212 in mCRPC
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2028-10
Enrollment target: 12 participants Locations- Adicet Clinical Trials, Redwood City, California, United States
Other microbiome trials you might be interested in
PROSTATE CANCERMetastatic Prostate CancerMetastatic Prostate Carcinoma
The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utili…
Boston, United StatesEst. completion Aug 28, 2027
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate CancerProstate Carcinoma
This is a single-center, open-label, study of Prostate-Specific Membrane Antigen (PSMA)-targeted radionuclide therapy wi…
San Francisco, United StatesEst. completion May 31, 2027